Axsome Therapeutics (AXSM) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts AXSM Hot Sheet
Join SI Premium – FREE
Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Axsome Therapeutics (AXSM) PT Raised to $316 at Mizuho
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
